中文名称达比加群

中文同义词达比加群;达比加群酯DABIGATRANETEXILATEMESILATE(研发中);达比加群,400G;达比加群,400G,5万;达比加群杂质B;N-[[2-[[[4-(氨咪甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-Β-丙氨酸;达比加群250MG;达比加群杂质C

英文名称Dabigatran

英文同义词3-[[2-[[(4-carbaMiMidoylphenyl)aMino]Methyl]-1-Met;BIBR953(Dabigatran);N-[[2-[[[4-(AMinoiMinoMethyl)phenyl]aMino]Methyl]-1-Methyl-1H-benzo[d]iMidazol-5-yl]carbonyl]-N-pyridin-2-yl-beta-alanine;N-[(2-{[(4-carbaMiMidoylphenyl)aMino]Methyl}-1-Methyl-1HbenziMidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine;BIBR953Chemicalbook(Dabigatran,Pradaxa);3-[[2-[[(4-carbaMiMidoylphenyl)aMino]Methyl]-1-Methyl-benzoiMidazole-5-carbonyl]-pyridin-2-yl-aMino];BIB-953;BIBR953ZW

CAS号211914-51-1

分子式C25H25N7O3

分子量471.51

EINECS号

相关类别小分子抑制剂，天然产物;达比加群酯杂质;医药中间体;吡啶;咪唑;原料药;中间体;信号转导通路激酶抑制剂;医药原料;原料;细胞生物学试剂;医药原料药-科研原料;对照品-杂质对照品;有机中间体;医药原料药科研原料;化工中间体;活性小分子库;Aromatics;Bases&RelatedReagents;Heterocycles;Intermediates&FineChemicals;Nucleotides;Pharmaceuticals;Inhibitor;OtherAPIs;Inhibitors;benzimidazol;Dabigatranimpurity;杂质对照品;对照品

Mol文件211914-51-1.mol